Safety and Efficacy of MD1003 (High-Dose Biotin) in Patients With Progressive Multiple Sclerosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Efficacy of MD1003 (High-Dose Biotin) in Patients With Progressive Multiple Sclerosis (SPI2): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial
Lancet Neurol 2020 Dec 01;19(12)988-997, BAC Cree, G Cutter, JS Wolinsky, MS Freedman, G Comi, G Giovannoni, HP Hartung, D Arnold, J Kuhle, V Block, FE Munschauer, F Sedel, FD LublinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.